Free Trial
NYSEAMERICAN:VTAK

Catheter Precision (VTAK) Stock Price, News & Analysis

Catheter Precision logo
$0.42 0.00 (-1.02%)
(As of 11:20 AM ET)

About Catheter Precision Stock (NYSEAMERICAN:VTAK)

Key Stats

Today's Range
$0.41
$0.44
50-Day Range
N/A
52-Week Range
$0.31
$8.40
Volume
37,412 shs
Average Volume
1.04 million shs
Market Capitalization
$411,543.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Catheter Precision Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
5th Percentile Overall Score

VTAK MarketRank™: 

Catheter Precision scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Catheter Precision.

  • Earnings Growth

    Earnings for Catheter Precision are expected to grow in the coming year, from ($8.90) to ($6.30) per share.

  • Price to Book Value per Share Ratio

    Catheter Precision has a P/B Ratio of 0.03. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.35% of the float of Catheter Precision has been sold short.
  • Short Interest Ratio / Days to Cover

    Catheter Precision has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Catheter Precision has recently increased by 205.15%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Catheter Precision does not currently pay a dividend.

  • Dividend Growth

    Catheter Precision does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.35% of the float of Catheter Precision has been sold short.
  • Short Interest Ratio / Days to Cover

    Catheter Precision has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Catheter Precision has recently increased by 205.15%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Catheter Precision this week, compared to 0 articles on an average week.
  • Search Interest

    Only 2 people have searched for VTAK on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Catheter Precision to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Catheter Precision insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.20% of the stock of Catheter Precision is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 20.34% of the stock of Catheter Precision is held by institutions.

  • Read more about Catheter Precision's insider trading history.
Receive VTAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Catheter Precision and its competitors with MarketBeat's FREE daily newsletter.

VTAK Stock News Headlines

Catheter Ekes up on Order for Product
Catheter Precision announces LockeT purchase from Montefiore Medical
Trump said you could learn something from this man
Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.
Catheter Precision Reports Q3 2024 Financial Results
Catheter Precision reports Q3 revenue $96,000
Catheter Precision, Inc. (VTAK)
See More Headlines

VTAK Stock Analysis - Frequently Asked Questions

Catheter Precision shares reverse split before market open on Monday, July 15th 2024. The 1-10 reverse split was announced on Monday, July 15th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of VTAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Catheter Precision investors own include ARMOUR Residential REIT (ARR), Jiuzi (JZXN), Windtree Therapeutics (WINT), AMC Entertainment (AMC), Sphere 3D (ANY), BioCardia (BCDA) and Chemomab Therapeutics (CMMB).

Company Calendar

Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:VTAK
CIK
N/A
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Net Income
$-70,570,000.00
Net Margins
-2,928.32%
Pretax Margin
-2,928.32%

Debt

Sales & Book Value

Annual Sales
$440,000.00
Book Value
$12.97 per share

Miscellaneous

Free Float
849,000
Market Cap
$415,800.00
Optionable
N/A
Beta
-0.43
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (NYSEAMERICAN:VTAK) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners